Paulsen, E., Kilvaer, T., Rakaee, M., Richardsen, E., Hald, S., Andersen, S., . . . Donnem, T. (2017). CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: Diverging prognostic impact in primary tumors and lymph node metastases. Cancer Immunology, Immunotherapy, 66(11), 1449. https://doi.org/10.1007/s00262-017-2039-2
Chicago Style (17th ed.) CitationPaulsen, Erna-Elise, Thomas Kilvaer, Mehrdad Rakaee, Elin Richardsen, Sigurd Hald, Sigve Andersen, Lill-Tove Busund, Roy Bremnes, and Tom Donnem. "CTLA-4 Expression in the Non-small Cell Lung Cancer Patient Tumor Microenvironment: Diverging Prognostic Impact in Primary Tumors and Lymph Node Metastases." Cancer Immunology, Immunotherapy 66, no. 11 (2017): 1449. https://doi.org/10.1007/s00262-017-2039-2.
MLA (9th ed.) CitationPaulsen, Erna-Elise, et al. "CTLA-4 Expression in the Non-small Cell Lung Cancer Patient Tumor Microenvironment: Diverging Prognostic Impact in Primary Tumors and Lymph Node Metastases." Cancer Immunology, Immunotherapy, vol. 66, no. 11, 2017, p. 1449, https://doi.org/10.1007/s00262-017-2039-2.